Aureus Sciences

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aureus Sciences

Life Sciences

Pharmacokinetic modelling & simulation
Founded Paris, France (2000)

Aureus Sciences (founded as Aureus Pharma) was a research-based company which sold software to the pharmaceutical industry for drug development.

The company's range of products included therapeutic target knowledgebases, ADME-based databases and software applications.

Aureus Sciences was formerly known as Aureus Pharma.[1] In January 2013, Aureus Sciences was acquired by Elsevier.[2]


Aureus' software applications allow in silico prediction of drug absorption, distribution, metabolism and excretion (ADME) and potential drug-drug interactions.

  • Knowledgebases : AurSCOPE Kinases, GPCR, Ion Channels, Proteases, Nuclear Receptors, ADME.[3]
  • Applications : AurQUEST, DDI Predict, AurPROFILER, AurPASS.[4]

The scientific background to Aureus' process is detailed in recent publications.[5][6]


  1. ^ "Aureus Pharma changes its name to Aureus Sciences ® and launches a new, comprehensive life science applications webportal". Aureus Sciences. 2011-01-20. Archived from the original (press release) on 2012-03-23. 
  2. ^ "Elsevier Acquires Aureus Sciences, Provider of Databases and Information Tools for Pharmaceutical and Biotech Companies" (press release). Elsevier. 2013-01-08. [permanent dead link]
  3. ^ Aureus knowledgebases Archived October 15, 2011, at the Wayback Machine.
  4. ^ Aureus applications Archived October 15, 2011, at the Wayback Machine.
  5. ^ Faure P, Dubus E, Ijjaali I, Morlière C, Barberan O, Petitet F (December 2010). "Knowledge-based analysis of multi-potent G-protein coupled receptors ligands". Eur. J. Med. Chem. 45 (12): 5708–5717. PMID 20933307. doi:10.1016/j.ejmech.2010.09.027. 
  6. ^ Dubus E, Ijjaali I, Barberan O, Petitet F (December 2009). "Drug repositioning using in silico compound profiling.". Future Med. Chem. 1 (9): 1723–36. PMID 21425988. doi:10.4155/fmc.09.123. 

External links[edit]